A Phase 1b/2a study to evaluate the efficacy and safety of BXQ-350 in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma patients (mCRC): Interim efficacy subset analyses

BXQ-350 - Bexion

Avastin (bevacizumab) - Roche

https://www.abstractsonline.com/pp8/#!/21436/presentation/12240

Daniel Flora1; Ari Baron2; Reema Patel3; Davendra Sohal4; Saima Sharif5; Fa Chyi Lee6; Julie Anne Gemmill7; Gilles H. Tapolsky8; James Beach8; Michael Gazda8; Tariq Arshad8

Mar 18, 2026